Jan 30
|
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member
|
Jan 29
|
Lantheus expands in neuro and oncology with LMI and Evergreen acquisitions
|
Jan 29
|
LNTH: Evergreen Acquisition Promotes Future Innovation
|
Jan 29
|
Why Lantheus Holdings Stock Got Thrashed on Tuesday
|
Jan 28
|
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio
|
Jan 28
|
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
|
Jan 27
|
MSD wins FDA priority review for Welireg in rare endocrine cancer
|